VivaCell-MTS and Nork-Marash Medical Center announce the launch of Mobile-Health pilot project

Yerevan/Mediamax/. VivaCell-MTS and the Cardiology Clinic of Nork-Marash Medical Center, in cooperation with Ericsson Nikola Tesla company have announced the launch of Mobile-Health pilot project.

Mobile-Health is a remote patient monitoring solution used for measurement and transfer of medical parameters from patient to healthcare staff. Measurements are taken at regular intervals or continuously and are transferred over mobile networks to healthcare provider/doctor. Patient makes measurements using special user friendly sensors such as a blood pressure monitor or ECG.

Each sensor set is equipped with a user-friendly automated Communication Device gathering data from the above-mentioned sensors via Bluetooth connection and transmitting information over VivaCell-MTS’ network to the back-end system and server, in a secure and accurate format allowing the medical personnel to check patient data in a convenient and efficient way via special web application.

Areas of application of the Mobile-Health are mostly in cardiology and pulmanology. The innovative solution can be used in remote diagnostics support, the treatment of chronically ill patients and those with long-term illnesses, as well as in the treatment of patients living in rural areas having insufficient access to medical care, patients discharged early from hospitals or those in homecare settings, post-operative monitoring, etc.

“Mobile-Health is the next innovative technology introduced by VivaCell-MTS to serve the health care needs of our compatriots as well as to enhance the capacity of our health care service providers in addressing major challenges such as chronic diseases and need for better geographical access to medical services. Thanks to Mobile-Health patients will be able to conduct medical measurements at home and instantly send health-related data remotely via VivaCell-MTS network to their doctors for monitoring using special mobile health equipment,” – said VivaCell-MTS General Manager Ralph Yirikian.